Meta-analyses, animal and clinical studies have demonstrated that depression can lead to elevated plasma inflammatory markers, such as interleukin-1 (IL-1), interleukin-2 (IL-2), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) (56–58). Here, IL2 is linked to depressive symptom measurement.